Healthcare PR - February 2011
21 Feb 2011 | by Claire Murphy
As pharma companies negotiate the prospect of a fundamentally changed NHS and a new drug pricing
will this mean for pharma marketers? Adam Hill finds out....Capita - for projects such as 'mock authorisation panels' and training programmes. Pharma is in a ...
As pharma companies negotiate the prospect of a fundamentally changed NHS and a new drug pricing